Is adenosine contraindicated in a young athlete with hypertrophic obstructive cardiomyopathy presenting with supraventricular tachycardia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adenosine is NOT absolutely contraindicated in HOCM, but requires extreme caution and should generally be avoided in favor of safer alternatives

Adenosine can be used in young athletes with hypertrophic obstructive cardiomyopathy (HOCM) presenting with supraventricular tachycardia, but verapamil poses a significantly greater risk and should be avoided. The 2015 ACC/AHA/HRS SVT guidelines 1, 2, 1 recommend adenosine as first-line therapy for acute SVT termination (Class I, Level B-NR) without specifically listing HOCM as a contraindication, while the FDA label 3 does not list HOCM among its contraindications. However, the 2011 ACCF/AHA HCM guideline 4 explicitly warns that verapamil can cause "pulmonary edema in patients with hypertrophic cardiomyopathy" 2, 1.

Clinical Approach for SVT in HOCM Patients

Start with vagal maneuvers (Valsalva, carotid massage, ice-cold towel to face) as these are Class I recommendations and carry no risk of hemodynamic compromise 1, 5.

If vagal maneuvers fail, adenosine is the preferred pharmacologic option over calcium channel blockers:

  • Adenosine 6 mg rapid IV push, followed by 12 mg if needed 1, 2, 1
  • Success rate 90-95% for AVNRT/AVRT 1
  • Half-life <10 seconds, so adverse effects are transient 1
  • Critical safety requirement: Have defibrillator immediately available, as adenosine can precipitate atrial fibrillation with rapid ventricular response or even ventricular fibrillation 1

Why Adenosine is Safer Than Verapamil in HOCM

The key pathophysiologic concern in HOCM is that negative inotropes and vasodilators can worsen left ventricular outflow tract (LVOT) obstruction:

  • Verapamil causes profound vasodilation and negative inotropy with prolonged duration, explicitly causing "pulmonary edema in patients with hypertrophic cardiomyopathy" 2, 1 and "hypotension, worsening HF in patients with pre-existing ventricular dysfunction" 2, 1
  • Adenosine has an ultra-short half-life (<10 seconds) 1, 3, so even if it causes transient hypotension or worsens LVOT obstruction, effects resolve almost immediately

Important Caveats and Pitfalls

Absolute contraindications to adenosine (regardless of HOCM status) 3:

  • Second- or third-degree AV block (without pacemaker)
  • Sick sinus syndrome
  • Asthma or bronchospastic lung disease
  • Known adenosine hypersensitivity

Common but transient side effects occur in ~30% of patients 1: flushing, chest discomfort, dyspnea, sense of impending doom—all resolve within 1 minute 1, 6, 7.

Rare but serious risks 3, 8:

  • Cardiac arrest (case reports exist 8)
  • Sustained ventricular tachycardia
  • Severe bronchospasm in asthmatics
  • Seizures (new-onset or recurrent)

Drug interactions 9:

  • Reduce initial dose to 3 mg if patient takes dipyridamole, carbamazepine, or has heart transplant
  • Higher doses may be needed with theophylline or caffeine

When to Proceed Directly to Cardioversion

Immediate synchronized cardioversion is indicated if 1, 5:

  • Hemodynamically unstable (systolic BP <80 mmHg, altered mentation, shock, acute heart failure)
  • Adenosine or vagal maneuvers fail
  • Patient has contraindications to adenosine

The 2025 AHA ACLS guidelines 5 emphasize that in hemodynamically unstable patients, "it is critical to promptly restore sinus rhythm" and cardioversion should not be delayed.

Beta-Blockers as Alternative

Beta-blockers (esmolol, metoprolol) are reasonable alternatives 5, 2, 1 and may be particularly appropriate in HOCM given their role in chronic HOCM management 4. However, they have slower onset than adenosine and carry risks of hypotension, worsening heart failure, and bronchospasm 2, 1.

Bottom Line Algorithm

  1. Hemodynamically unstable → Immediate cardioversion
  2. Hemodynamically stable → Vagal maneuvers
  3. If vagal maneuvers fail → Adenosine 6 mg IV push (with defibrillator ready)
  4. If adenosine fails or contraindicated → Consider beta-blocker or proceed to cardioversion
  5. Avoid verapamil/diltiazem in HOCM due to explicit risk of pulmonary edema 2, 1

The notion that adenosine is "contraindicated" in HOCM is a common misconception—it is not listed as a contraindication in either the SVT guidelines 1, 2, 1 or FDA labeling 3. The real contraindication is verapamil in HOCM.

References

Research

Adenosine and the treatment of supraventricular tachycardia.

The American journal of medicine, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.